Control (N = 86) | Bipolar I (N = 67) | Bipolar II (N = 43) | ANOVA | P | ||
---|---|---|---|---|---|---|
F | χ2 | |||||
Age, years: mean (SD) | 38.1 (14.5) | 38.3 (13.5) | 35.7 (12.0) | 0.562 | 0.57 | |
Gender (male / female) | 39 / 47 | 32 / 35 | 16 / 27 | 1.24 | 0.54 | |
Educational level,1-5: mean (SD)a | 4.1 | 3.8 | 3.8 | 1.08 | 0.34 | |
WAISinformation subtest | 13,3 (2,3) | 13,2 (2,3) | 13,6 (2,2) | 0,38 | 0,69 | |
Age of onset: mean (SD) | 20.6 (8.4) | 19.1 (8.5) | 0.88 | 0.35 | ||
Prior psychotic symptoms: N (%) | 52 (78) | 7 (17) | 39.6 | < 0.001 | ||
Suicide attempt: N (%) | 26 (39) | 16 (38) | 0.06 | 0.94 | ||
Interpersonal violence: N (%) | 20 (30) | 10 (23) | 0.57 | 0.45 | ||
Anxiety disorder | 19 (28) | 24 (56) | 7.96 | 0.005 | ||
ADHD | 7 (11)c | 10 (23) | 3.04 | 0.081 | ||
MADRS: mean (SD) | 3.9 (3.5) | 3.6 (3.6) | 0.17 | 0.68 | ||
YMRS: mean (SD) | 1.6 (2.7) | 2.2 (2.2) | 1.2 | 0.28 | ||
Lifetime number of manic episodes: mean (SD) | 3 (2.9) | - | ||||
Lifetime number of depressive episodes: mean (SD) | 13.3 (13.2) | 28.5 (31.0) | 12.4 | 0.001 | ||
CGI: mean (SD) | 4.9 (0.9) | 4.1 (0.7) | 23.2 | < 0.001 | ||
Pharmacological treatment, N (%) | ||||||
Lithium | 49 (73) | 21 (49) | 6.7 | 0.01 | ||
Anticonvulsant | 15 (22) | 8 (19) | 0.22 | 0.63 | ||
Antidepressant | 18 (27) | 19 (44) | 3.5 | 0.061 | ||
Antipsychotic | 22 (33) | 6 (14) | 4.9 | 0.027 | ||
Combination therapyb | 34 (51) | 17 (40) | 1.32 | 0.25 |